EC concludes negotiations with Valneva on procurement of 30m vaccine doses

The European Commission on Wednesday informed that it had concluded preliminary talks with the French Valneva biotech company, specialised in developing and commercializing vaccines for infectious diseases, on the procurement of its potential vaccine against COVID-19. Pročitaj više